Literature DB >> 22840747

Altering mitochondrial dysfunction as an approach to treating Alzheimer's disease.

Jerry R Colca1, Douglas L Feinstein.   

Abstract

Mitochondrial dysfunction appears to be a precipitating or exacerbating factor in both familial and late stage Alzheimer's disease. This chapter summarizes various mechanisms by which dysfunction of mitochondrial metabolism can be involved in loss of cognitive function as well as in the exacerbation of structural changes in the signature pathology of Alzheimer's disease. Although currently few in number, a number of mitochondrially directed/metabolic approaches are now being tried that include limiting the damage caused by dysfunctional oxidative metabolism. There is a clear need to identify and test specific targets to take advantage of a growing understanding in this field. The eventual successful approach to meaningfully treat Alzheimer's disease will likely include treatments aimed at correction of the mitochondrial dysfunction component.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22840747     DOI: 10.1016/B978-0-12-394816-8.00005-2

Source DB:  PubMed          Journal:  Adv Pharmacol        ISSN: 1054-3589


  4 in total

Review 1.  The Complex Role of Apolipoprotein E in Alzheimer's Disease: an Overview and Update.

Authors:  Laura Mahoney-Sanchez; Abdel Ali Belaidi; Ashley I Bush; Scott Ayton
Journal:  J Mol Neurosci       Date:  2016-09-19       Impact factor: 3.444

Review 2.  The Role of TDP-43 in Alzheimer's Disease.

Authors:  Xiao-Long Chang; Meng-Shan Tan; Lan Tan; Jin-Tai Yu
Journal:  Mol Neurobiol       Date:  2015-06-17       Impact factor: 5.590

Review 3.  Metabolic Mechanisms Connecting Alzheimer's and Parkinson's Diseases: Potential Avenues for Novel Therapeutic Approaches.

Authors:  Jerry R Colca; Brian N Finck
Journal:  Front Mol Biosci       Date:  2022-06-16

4.  An evaluation of MSDC-0160, a prototype mTOT modulating insulin sensitizer, in patients with mild Alzheimer's disease.

Authors:  Raj C Shah; Dawn C Matthews; Randolph D Andrews; Ana W Capuano; Debra A Fleischman; James T VanderLugt; Jerry R Colca
Journal:  Curr Alzheimer Res       Date:  2014       Impact factor: 3.498

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.